Laboratory Corporation of America
In Brief This Week: Labcorp, Abbott, Danaher, MeMed, Co-Diagnostics, More
News items for the week of Dec. 9, 2024.
Top Five Articles on 360Dx Last Week: Roche Mpox Test Approved; Quest Diagnostics Revenues up; More
Last week, readers were most interested in a story about WHO approving Roche’s molecular mpox assay under the organization’s EUL procedure.
Labcorp Q3 Revenues Rise 7 Percent
Total revenues for Q3 were $3.28 billion, up from $3.06 billion in the third quarter of 2023, and above the consensus Wall Street estimate of $3.26 billion.
Quest Diagnostics Wins CDC Contracts for Avian Flu, Oropouche Testing
Quest has developed a multi-target molecular test for avian influenza A H5 virus that it plans to make available by the end of October.
Retirements and the outcomes of a handful of close races could reshape congressional committees tasked with oversight of issues important to labs.
Sep 24, 2024
Labcorp Closes $2B Senior Notes Public Offering
Aug 1, 2024
Labcorp Q2 Revenues up 6 Percent
Jul 29, 2024
Jul 10, 2024